surpass cvot tirzepatide results cardiovascular outcomes trial july 2025 SURPASS-CVOT Published: Large Confirms CVD Efficacy of ❇️ Cardiovascular Outcomes with Tirzepatide – A comparison of the effects

Hypertension developed in 16.6 per cent of women who experienced menopause after 45, compared with 18.8 per cent of those who reached menopause between 40 and 45

Addressing melanin-filled cells as well as areas of inflammation, the brand's innovative technology seeks to regulate melanin production for a more unified skin tone

When these small deposits enter your ureter (the tube that carries urine from the kidney to the bladder) and make their way toward your bladder, they typically cause pain, and can cause other issues too

The future of addiction treatment GLP-1 drugs are the first type of medication to show potential benefit across multiple substance types simultaneously

Patients can switch to other methods, such as daily gel, daily oral pill, or the vaginal ring (Femring)